- CSR Summary Not Available
- NCT02698475 Not Available
- Primary Citation Trial has yet to be published
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameUstekinumabProduct NameSTELARA®Therapeutic AreaImmune System DiseasesEnrollment44% Female61.40%%% White90.90%%
Product ClassAntipsoriaticsSponsor Protocol NumberCNTO1275PSO3013Data PartnerJohnson & JohnsonCondition StudiedPsoriasisMean/Median Age (Years)8.9
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available